Developmental variability of metallothionein Mtn gene expression in the species of the Drosophila melanogaster subgroup.

Dev Genet

Laboratoire d'Embryologie Moléculaire et Expérimentale, Université de Paris XI, Orsay, France.

Published: July 1995

Developmental expression of the Drosophila melanogaster metallothionein Mtn gene has been analysed. Transcripts of this gene accumulate during the vitellogenic phase of oogenesis in a ring of follicular cells at the oocyte-nurse cell margin and in the follicular cells surrounding the oocyte. There is also strong expression of the Mtn gene during the second half of embryogenesis in hemocytes, the endoderm midgut, and Malpighian tubules. A banded expression pattern is observed transiently in the midgut at stage 13. The two Mtn alleles, Mtn and Mtn, show quantitative differences in their expression patterns. Copper intoxication of flies does not induce ectopic expression of the Mtn gene, but rather leads to over-expression of the gene in the structures where it is normally transcribed. Mtn transcription is not altered in homozygous mutants of four genes (lab, wg, dpp, bap) known to be involved in midgut morphogenesis. Expression of Mtn has been also studied in six other species of the melanogaster subgroup. This analysis demonstrates that regulation of Mtn gene transcription has changed during evolution of the Drosophila lineage. For example, Mtn is expressed specifically in the Malpighian tubules of D. melanogaster, while in D. mauritiana and D. sechellia the amnioserosa is a specific location of expression. Nonetheless, expression of Mtn in the midgut is common to the seven species, suggesting a basic role for the MTN protein during embryogenesis in this organ, possibly in the release of metallic ions from vitellogenins. In contrast, two genes also expressed in the embryonic midgut, lab and dFRA, display identical patterns in all species of the melanogaster subgroup. The diversity of Mtn patterns in closely related Drosophila species exemplifies the rapid evolution of a gene regulatory system.

Download full-text PDF

Source
http://dx.doi.org/10.1002/dvg.1020160305DOI Listing

Publication Analysis

Top Keywords

mtn gene
20
expression mtn
16
mtn
14
melanogaster subgroup
12
expression
9
metallothionein mtn
8
gene
8
drosophila melanogaster
8
follicular cells
8
malpighian tubules
8

Similar Publications

Article Synopsis
  • Researchers investigated whether SARS-CoV-2 RNA can be found on the skin of COVID-19 patients by analyzing skin surface lipids (SSLs) collected from their faces.
  • Using RT-PCR, they found that 84.6% of samples tested positive within 5 days of symptom onset, while only 30.4% tested positive between 6-10 days.
  • The study also revealed an increase in specific genes related to the immune response in the skin samples, highlighting a new method for detecting the virus and studying its impact on human health non-invasively.
View Article and Find Full Text PDF

Background: Access to allogeneic haematopoietic stem-cell transplantation (HSCT) remains challenging for older patients (aged >60 years) with acute myeloid leukaemia. We aimed to evaluate the efficacy of venetoclax plus decitabine as first-line therapy and bridge to transplantation in this patient population.

Methods: This multicentre, single-arm, phase 2 trial was conducted in 20 Gruppo Italiano Trapianto Midollo Osseo (GITMO) centres in Italy.

View Article and Find Full Text PDF

Customised design of antisense oligonucleotides targeting EGFR driver mutants for personalised treatment of non-small cell lung cancer.

EBioMedicine

October 2024

Department of Pharmacology and Institute for Digital Medicine, Yong Loo Lin School of Medicine, National University of Singapore, 16 Medical Drive, Singapore, 117600, Republic of Singapore; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, 1E Kent Ridge Road, Singapore, 119228, Republic of Singapore; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research, (A∗STAR), 61 Biopolis Street, Proteos, Singapore, 138673, Republic of Singapore. Electronic address:

Article Synopsis
  • Tyrosine kinase inhibitors (TKIs) are the main treatment for non-small cell lung cancer (NSCLC) with EGFR mutations, but resistance to these drugs often develops due to new mutations and they can cause severe side effects.
  • Researchers are exploring customized antisense oligonucleotides (ASOs) to specifically target these mutations, using extracellular vesicles to deliver them directly to cancer cells.
  • Preliminary results show that ASOs can effectively reduce tumor growth in models of NSCLC and may work better than TKIs, offering a promising new treatment approach tailored to individual genetic profiles.
View Article and Find Full Text PDF

Accurate and Automated Genotyping of the Poly-T/TG Tract with -TIPS.

Int J Mol Sci

August 2024

Division of Laboratory Genetics and Genomics, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN 55905, USA.

Article Synopsis
  • * The new web-based tool, -TIPS, simplifies the genotyping process from Sanger sequencing data by detecting and analyzing the (TG)T tract effectively, providing a user-friendly interface.
  • * In tests with clinical samples, -TIPS demonstrated an impressive 99.8% accuracy compared to traditional methods and offers a quick analysis time of under 10 seconds per sample, making it a valuable resource for CFTR genotyping.
View Article and Find Full Text PDF

Extracellular vesicle surface display enhances the therapeutic efficacy and safety profile of cancer immunotherapy.

Mol Ther

October 2024

Institute for Digital Medicine and Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore; Department of Surgery, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117600, Singapore; Institute of Molecular and Cell Biology, A∗STAR, Singapore 138673, Singapore. Electronic address:

Immunotherapy has emerged as a mainstay in cancer therapy, yet its efficacy is constrained by the risk of immune-related adverse events. In this study, we present a nanoparticle-based delivery system that enhances the therapeutic efficacy of immunomodulatory ligands while concurrently limiting systemic toxicity. We demonstrate that extracellular vesicles (EVs), lipid bilayer enclosed particles released by cells, can be efficiently engineered via inverse electron demand Diels-Alder (iEDDA)-mediated conjugation to display multiple immunomodulatory ligands on their surface.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!